Status:

RECRUITING

Londrina Activities of Daily Living Protocol in Pulmonary Hypertension

Lead Sponsor:

Saglik Bilimleri Universitesi

Conditions:

Pulmonary Hypertension

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this observational study is to evaluate the validity and reliability of the Londrina Daily Living Activities Protocol in patients diagnosed with pulmonary hypertension (PH).

Detailed Description

Pulmonary hypertension (PH) is a progressive cardiopulmonary disorder characterized by elevated pulmonary artery pressure, which can lead to right ventricular dysfunction and ultimately heart failure....

Eligibility Criteria

Inclusion

  • Being diagnosed with pulmonary hypertension (PH)
  • Being 18 years of age or older
  • Agreeing to participate in the study

Exclusion

  • Acute decompensated heart failure
  • Orthopedic or neurological disorders that prevent the test from being performed
  • Patients who have difficulty understanding the instructions given

Key Trial Info

Start Date :

September 15 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 26 2025

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT07206173

Start Date

September 15 2025

End Date

December 26 2025

Last Update

November 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istanbul University - Cerrahpasa

Istanbul, Turkey (Türkiye)